Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update

SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update

SRx Health Solutions announced a new investment in Uber Technologies, Inc. as part of portfolio adjustments including reduced exposure to Compass, Inc. and Bitcoin, and adding hedges in select international markets. This repositioning comes in response to the EMJX stress model turning negative after a sustained bullish period, prompting a more caut…

Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment

Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment

Clearmind Medicine Inc., a clinical-stage biotech company, announced the filing of a Japanese patent application for its proprietary non-hallucinogenic psychedelic-based compound MEAI, designed for treating depression. This move expands Clearmind's intellectual property portfolio globally and aligns with its focus on neuroplastogen-derived therapeu…

Lianhe Sowell International Group Ltd. Announces Results of Extraordinary General Meeting of Shareholders on May 29, 2026

Lianhe Sowell International Group Ltd. Announces Results of Extraordinary General Meeting of Shareholders on May 29, 2026

Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision and robotics solutions, announced the approval of five key proposals at its extraordinary general meeting held on May 29, 2026. These include a 16-for-1 share consolidation, a significant increase in authorized share capital from $50,000 to $80 million, am…

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Optimi Health Corp. acknowledged Australia's Therapeutic Goods Administration updated Authorized Prescriber framework, broadening therapist eligibility and treatment settings for psychedelic-assisted therapies using Optimi's MDMA and psilocybin products. These changes support scalable commercial growth as Australia leads globally in prescribed psyc…

Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits

Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits

Moleculin Biotech announced new data at ASCO 2026 demonstrating that Annamycin, their lead drug candidate, shows no detectable cardiotoxicity even at cumulative doses far exceeding conventional anthracycline limits. An independent review by Cleveland Clinic specialists supports a differentiated cardiac safety profile. The data bolster ongoing pivot…

SAIC Board of Directors Declares Cash Dividend

SAIC Board of Directors Declares Cash Dividend

Science Applications International Corp. (SAIC) announced a cash dividend of $0.37 per share payable on July 24, 2026, to shareholders of record as of July 10, 2026. SAIC intends to continue quarterly dividend payments, subject to board approval each quarter, based on earnings and financial condition. The company is a leading mission integrator spe…

SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting

SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting

SAB Biotherapeutics announced that it will present clinical data on SAB-142, its lead immunotherapy candidate for newly diagnosed Stage 3 type 1 diabetes, at the American Diabetes Association's 2026 Scientific Sessions and the Federation of Clinical Immunology Societies 2026 Annual Meeting. The presentations will showcase SAB-142's safety, pharmaco…

SunPower Achieves High NPS Score from Starbucks

SunPower Achieves High NPS Score from Starbucks

SunPower Inc. announced that it successfully completed 26 commercial solar projects for Starbucks, receiving a 90% Net Promoter Score (NPS) from the client, highlighting exceptional product quality, installation performance, and customer support. This achievement underscores SunPower's commitment to quality and customer satisfaction in the solar se…

DarkIris Announces Commercial Launch of AIGC Video Platform, video.aideptus.com, Integrating ByteDance’s Seedance 2.0 Model

DarkIris Announces Commercial Launch of AIGC Video Platform, video.aideptus.com, Integrating ByteDance’s Seedance 2.0 Model

DarkIris Inc. announced the commercial launch of its generative AI video platform, video.aideptus.com, incorporating ByteDance’s advanced Seedance 2.0 multimodal AI model. The platform initially supports a Simplified Chinese interface with further localizations planned, targeting digital media content creators to enhance video production efficiency…

QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

QTREX Quantum Ltd., a Nasdaq-listed company specializing in additively manufactured electronics for quantum hardware infrastructure, announced a $10 million private placement with a new institutional investor. The proceeds will support commercialization of its cryogenic interconnect platform, scale acquired AME capabilities, and advance R&D in quan…

HomesToLife Delivers 36% Increase in Q1 2026 Net Profit to $3.2 Million on Export Growth and Stronger Margins

HomesToLife Delivers 36% Increase in Q1 2026 Net Profit to $3.2 Million on Export Growth and Stronger Margins

HomesToLife Ltd, a Singapore-based home furniture company listed on Nasdaq, announced a 36% increase in net profit for Q1 2026 to $3.2 million, propelled by a 16% rise in net revenue to $92.5 million and a 3.8 percentage points expansion in gross margin to 29.0%. Export sales growth of 17% notably in Europe and North America, alongside retail sales…

The Elmet Group Co. Reports First Quarter 2026 Results

The Elmet Group Co. Reports First Quarter 2026 Results

The Elmet Group Co., a U.S.-based precision-engineered components and high-power systems provider, announced a 20.7% revenue increase in Q1 2026 to $56 million, driven primarily by growth in the Aerospace, Defense & Government segment. Gross profit margins expanded by 260 basis points, contributing to an adjusted EBITDA increase of 106%. The compan…